(Q38120201)

PubMed publication ID

23836237

29 August 2017

title

Current progress in development of hepatitis C virus vaccines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6263146&resulttype=core&format=json

13 May 2020

1 reference

1 reference

T Jake Liang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6263146&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

1 July 2013

1 reference

PubMed publication ID

29 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6263146&resulttype=core&format=json

13 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6263146&resulttype=core&format=json

13 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6263146&resulttype=core&format=json

13 May 2020

page(s)

869-878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6263146&resulttype=core&format=json

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

13 May 2020

cites work

1 reference

Pathogenesis, natural history, treatment, and prevention of hepatitis C.

21 January 2018

1 reference

Adaptive immune responses in acute and chronic hepatitis C virus infection

21 January 2018

1 reference

Unravelling hepatitis C virus replication from genome to function

21 January 2018

1 reference

Peginterferon and ribavirin for chronic hepatitis C.

21 January 2018

1 reference

Anti-hepatitis C virus drugs in development

21 January 2018

1 reference

Current and future therapies for hepatitis C virus infection

21 January 2018

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

21 January 2018

1 reference

Evolution of infection control in Egypt: achievements and challenges

21 January 2018

1 reference

Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors

21 January 2018

1 reference

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting.

21 January 2018

1 reference

Public health impact of antiviral therapy for hepatitis C in the United States

21 January 2018

1 reference

Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection

21 January 2018

1 reference

Antiviral agents and HIV prevention: controversies, conflicts, and consensus

21 January 2018

1 reference

Post-step modifications for research on HIV vaccines

21 January 2018

1 reference

Overview of STEP and Phambili trial results: two phase IIb test-of-concept studies investigating the efficacy of MRK adenovirus type 5 gag/pol/nef subtype B HIV vaccine

21 January 2018

1 reference

Nucleic acid testing to detect HBV infection in blood donors

21 January 2018

1 reference

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

21 January 2018

1 reference

Cross-genotype immunity to hepatitis C virus

21 January 2018

1 reference

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection

21 January 2018

1 reference

The natural history of hepatitis C virus infection: host, viral, and environmental factors

21 January 2018

1 reference

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

21 January 2018

1 reference

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

21 January 2018

1 reference

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

Host genetic determinants in hepatitis C virus infection

21 January 2018

1 reference

Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies

21 January 2018

1 reference

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection

21 January 2018

1 reference

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

21 January 2018

1 reference

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus

21 January 2018

1 reference

Neutralizing antibody response during acute and chronic hepatitis C virus infection

21 January 2018

1 reference

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity

21 January 2018

1 reference

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

21 January 2018

1 reference

Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles

21 January 2018

1 reference

Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort

21 January 2018

1 reference

Analysis of a successful immune response against hepatitis C virus

21 January 2018

1 reference

Neutralizing antibodies to hepatitis C virus in perinatally infected children followed up prospectively

21 January 2018

1 reference

Adaptive immune features of natural killer cells

21 January 2018

1 reference

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons

21 January 2018

1 reference

Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees

21 January 2018

1 reference

Animal models for the study of hepatitis C virus infection and related liver disease

21 January 2018

1 reference

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes

21 January 2018

1 reference

Rates of evolutionary change in viruses: patterns and determinants

21 January 2018

1 reference

Mutational escape from CD8+ T cell immunity: HCV evolution, from chimpanzees to man

21 January 2018

1 reference

Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo

21 January 2018

1 reference

Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution

21 January 2018

1 reference

Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope

21 January 2018

1 reference

Applications for T-cell epitope queries and tools in the Immune Epitope Database and Analysis Resource

21 January 2018

1 reference

Unresponsiveness to a foreign antigen can be caused by self-tolerance

21 January 2018

1 reference

Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.

21 January 2018

1 reference

Rational antibody-based HIV-1 vaccine design: current approaches and future directions

21 January 2018

1 reference

Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1

21 January 2018

1 reference

Trends in vaccine adjuvants.

21 January 2018

1 reference

Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses

21 January 2018

1 reference

Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion

21 January 2018

1 reference

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

21 January 2018

1 reference

Vaccination of chimpanzees against infection by the hepatitis C virus

21 January 2018

1 reference

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

Mouse models for the study of HCV infection and virus–host interactions

21 January 2018

1 reference

Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus

21 January 2018

1 reference

Immunization of human volunteers with hepatitis C virus envelope glycoproteins elicits antibodies that cross-neutralize heterologous virus strains

21 January 2018

1 reference

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

21 January 2018

1 reference

Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes

21 January 2018

1 reference

Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a.

21 January 2018

1 reference

A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

21 January 2018

1 reference

A genetically humanized mouse model for hepatitis C virus infection

21 January 2018

1 reference

T‐cell‐inducing vaccines – what’s the future

21 January 2018

1 reference

Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus

21 January 2018

1 reference

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity

21 January 2018

1 reference

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.

21 January 2018

1 reference

A Poxvirus Vaccine Is Safe, Induces T-Cell Responses, and Decreases Viral Load in Patients With Chronic Hepatitis C

21 January 2018

1 reference

Viral vectors as vaccine platforms: deployment in sight

21 January 2018

1 reference

Application of electroporation in DNA vaccination protocols

21 January 2018

1 reference

Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee

21 January 2018

1 reference

Therapeutic vaccination of chronic hepatitis C nonresponder patients with the peptide vaccine IC41.

21 January 2018

1 reference

Adaptive Immunity to the Hepatitis C Virus

21 January 2018

1 reference

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

The coming of age of virus-like particle vaccines

21 January 2018

1 reference

Developments in virus-like particle-based vaccines for infectious diseases and cancer

21 January 2018

1 reference

Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes

21 January 2018

1 reference

Immunogenic display of diverse peptides, including a broadly cross-type neutralizing human papillomavirus L2 epitope, on virus-like particles of the RNA bacteriophage PP7

21 January 2018

1 reference

Alum adjuvant: some of the tricks of the oldest adjuvant

21 January 2018

1 reference

Immunology of TLR-independent vaccine adjuvants

21 January 2018

1 reference

Immunomodulators as adjuvants for vaccines and antimicrobial therapy

21 January 2018

1 reference

Adjuvant activity of cytokines

21 January 2018

1 reference

Meta-analysis of hepatitis C virus vaccine efficacy in chimpanzees indicates an importance for structural proteins

21 January 2018

1 reference

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

21 January 2018

1 reference

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses

21 January 2018

1 reference

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

21 January 2018

1 reference

Hepatitis C vaccine: supply and demand

21 January 2018

1 reference

Acute hepatitis C: a multifaceted disease

21 January 2018

1 reference

Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Antibodies, viruses and vaccines

21 January 2018

1 reference

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers

21 January 2018

1 reference

A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers

21 January 2018

1 reference

Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.

21 January 2018

1 reference

Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response

21 January 2018

1 reference

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

21 January 2018

1 reference

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

21 January 2018

1 reference

Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders

21 January 2018

1 reference

The SH3 binding motif of HCV [corrected] NS5A protein interacts with Bin1 and is important for apoptosis and infectivity

21 January 2018

1 reference

Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway

21 January 2018

1 reference

Potential cost-effectiveness of a preventive hepatitis C vaccine in high risk and average risk populations in Canada

21 January 2018

1 reference

Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase

21 January 2018

1 reference

12 December 2020

Lessons from Chimpanzee-based Research on Human Disease: The Implications of Genetic Differences

1 reference

12 December 2020

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

1 reference

12 December 2020

Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines

1 reference

12 December 2020

Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up

1 reference

12 December 2020

Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections

1 reference

12 December 2020

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine

1 reference

12 December 2020

Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector function

1 reference

12 December 2020

Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire

1 reference

12 December 2020

T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections

1 reference

7 January 2021

inferred from DOI database lookup

Regulation of hepatic innate immunity by hepatitis C virus

1 reference

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NM.3183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6263146&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6263146&resulttype=core&format=json

13 May 2020

PubMed publication ID

23836237

1 reference